Driehaus Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-63,000
| Closed | -$6.26M | – | 632 |
|
|
2019
Q3 | $6.26M | Hold |
63,000
| – | – | 0.2% | 130 |
|
|
2019
Q2 | $5.82M | Buy |
63,000
+16,572
| +36% | +$1.57M | 0.18% | 145 |
|
|
2019
Q1 | $4.38M | Buy |
+46,428
| New | +$4.06M | 0.16% | 149 |
|
|
2017
Q2 | – | Sell |
-5,829
| Closed | -$725K | – | 718 |
|
|
2017
Q1 | $725K | Buy |
+5,829
| New | +$698K | 0.02% | 401 |
|
|
2016
Q3 | – | Sell |
-29,448
| Closed | -$2.9M | – | 688 |
|
|
2016
Q2 | $2.9M | Sell |
29,448
-3,389
| -10% | -$351K | 0.1% | 200 |
|
|
2016
Q1 | $3.29M | Buy |
32,837
+2,595
| +9% | +$267K | 0.11% | 195 |
|
|
2015
Q4 | $3.62M | Buy |
30,242
+4,896
| +19% | +$566K | 0.12% | 188 |
|
|
2015
Q3 | $2.74M | Sell |
25,346
-2,518
| -9% | -$312K | 0.1% | 221 |
|
|
2015
Q2 | $3.23M | Sell |
27,864
-167
| -0.6% | -$19.1K | 0.11% | 233 |
|
|
2015
Q1 | $3.23M | Buy |
28,031
+4,309
| +18% | +$515K | 0.11% | 232 |
|
|
2014
Q4 | $2.65M | Sell |
23,722
-12,538
| -35% | -$1.32M | 0.11% | 249 |
|
|
2014
Q3 | $3.44M | Sell |
36,260
-60,429
| -62% | -$5.45M | 0.13% | 210 |
|
|
2014
Q2 | $8.3M | Sell |
96,689
-4,927
| -5% | -$375K | 0.27% | 93 |
|
|
2014
Q1 | $7.09M | Buy |
101,616
+18,458
| +22% | +$1.46M | 0.22% | 127 |
|
|
2013
Q4 | $7.03M | Buy |
83,158
+43,740
| +111% | +$3.46M | 0.25% | 121 |
|
|
2013
Q3 | $3.03M | Buy |
+39,418
| New | +$2.76M | 0.12% | 229 |
|
Other funds holding CELG
Driehaus Capital Management's CELG Position: Q4 2019 in Review
Driehaus Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 63,000 shares — an estimated $6.26M sold.
Driehaus Capital Management first reported a position in CELG in Q3 2013 and held it in 16 quarters. The position peaked at $8.3M in Q2 2014. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Driehaus Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Driehaus Capital Management sold 63,000 Celgene Corp shares in Q4 2019, an estimated $6.26M.
- Driehaus Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 16 quarters.
- Driehaus Capital Management's Celgene Corp position peaked at $8.3M in Q2 2014.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Driehaus Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.